Cancer News and Research

Latest Cancer News and Research

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function.

12 Nov 2009

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Allos Therapeutics, Inc. today announced that abstracts from studies of FOLOTYN™ (pralatrexate injection) were accepted for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held at the Ernest N. Morial Convention Center in New Orleans, La., from December 5-8, 2009.

12 Nov 2009

Stapled Peptides can inhibit key intracellular biological targets, says new research

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.

12 Nov 2009

54% of Americans are inconsistent in taking prescriptions, reveals survey

A new survey finds that 54 percent of Americans say they do not consistently take prescriptions as instructed even though 87 percent believe prescription medicines are important to their health – pointing to a growing public health problem.

12 Nov 2009

Nuvo Research announces new licensing agreement for Oxoferin

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.

12 Nov 2009

Scientists report largest-ever collection of data about the proteins produced by genes in a single human organ

Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ. Their focus was the liver, and their massive database in both protein and transcript levels could become a roadmap for finding possible new biomarkers and treatments for liver disease.

12 Nov 2009

IMS Health to launch comprehensive analytical tool for oncology market

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company’s clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

12 Nov 2009

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in the November 12 issue of Nature, lays the foundation for a new kind of therapy aimed directly at a critical human protein — one of a few thousand so-called transcription factors — that could someday be used to treat a variety of diseases, especially multiple types of cancer.

12 Nov 2009

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.

12 Nov 2009

Shimadzu, EDDA sign business deal

Shimadzu Corporation (Kyoto Japan) and EDDA Technology Inc. (Princeton, NJ, USA) today announced that both parties have entered into a business partnership on X-ray chest CAD systems based on the Radiography System of Shimadzu featuring its direct conversion flat panel detector (FPD) and EDDA's CAD applications.

12 Nov 2009

Researchers identify a new mechanism that inhibits the formation of new blood vessels

Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research.

12 Nov 2009

Study: Mouse gene uncovers new strategy for treating Alzheimer's disease

A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD). The research, published by Cell Press in the November 12 issue of the journal Neuron, finds that the novel gene interacts with a key cellular enzyme previously linked with AD pathology, thereby uncovering a new strategy for treating this devastating disorder.

12 Nov 2009

Researchers identify mouse gene that reduces the accumulation Alzheimer's plaques and tangles

Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau. The amyloid and tau lowering functions of this gene were demonstrated in both human and mouse cells.

12 Nov 2009

Experts recommend nicotine replacement products and counseling to quit smoking

Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult. Various nicotine replacement products are on the market to make quitting easier. But which product is right for you? Experts from The University of Texas M. D. Anderson Cancer Center are here to help.

12 Nov 2009

Researchers find link between telomeres and longevity

A team led by researchers at Albert Einstein College of Medicine of Yeshiva University has found a clear link between living to 100 and inheriting a hyperactive version of an enzyme that rebuilds telomeres - the tip ends of chromosomes. The findings appear in the latest issue of the Proceedings of the National Academy of Sciences.

12 Nov 2009

LCA launches webpage with information on lung cancer meant for veterans

Lung Cancer Alliance (LCA) salutes all veterans today on Veterans Day and announces the launch of a new webpage with information specifically for veterans on lung cancer -- the leading cause of cancer death among veterans.

12 Nov 2009

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

Endo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.

11 Nov 2009

Report predicts Africa's tobacco use will double within 12 years without intervention

"Africa faces a surge in cancer deaths unless action is taken in the next decade to stem rising smoking levels in a continent where anti-tobacco laws remain rare, U.S. scientists said Wednesday," Reuters reports (Kelland, 11/11).

11 Nov 2009

OPKO Health acquires NK-1 compounds from Schering

OPKO Health, Inc. today announced that it has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co., Inc. ("Schering").

11 Nov 2009

New robotic surgical systems from El Camino Hospital

El Camino Hospital, the hospital of Silicon Valley, expands its minimally invasive surgical program to three da Vinci® Si HD Surgical Systems. Physicians performed more than 500 robotic surgeries over the past year and expect the number to increase in 2010 as more physicians undergo training with the enhanced equipment that allows for more minimally invasive procedures.

11 Nov 2009

Cancer News and Research

Latest Cancer News and Research

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

Stapled Peptides can inhibit key intracellular biological targets, says new research

54% of Americans are inconsistent in taking prescriptions, reveals survey

Nuvo Research announces new licensing agreement for Oxoferin

Scientists report largest-ever collection of data about the proteins produced by genes in a single human organ

IMS Health to launch comprehensive analytical tool for oncology market

Scientists find way to disarm "undruggable" protein; discovery lays foundation for new kind of cancer therapy

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Shimadzu, EDDA sign business deal

Researchers identify a new mechanism that inhibits the formation of new blood vessels

Study: Mouse gene uncovers new strategy for treating Alzheimer's disease

Researchers identify mouse gene that reduces the accumulation Alzheimer's plaques and tangles

Experts recommend nicotine replacement products and counseling to quit smoking

Researchers find link between telomeres and longevity

LCA launches webpage with information on lung cancer meant for veterans

Endo Pharmaceuticals reaches patent litigation settlement with LecTec

Report predicts Africa's tobacco use will double within 12 years without intervention

OPKO Health acquires NK-1 compounds from Schering

New robotic surgical systems from El Camino Hospital

Cancer Research - Second Edition eBook

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Newsletters you may be interested in